| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536155 | Tuberculosis | 2017 | 23 Pages |
Abstract
The high frequency of M. bovis reinforces the impact of the pathogen as a major causal agent of bovine tuberculosis in the study area. The resistance of the strains to drugs used for first-line treatment of human tuberculosis raises public health concerns. Further studies are required to elucidate the basis of drug resistance and genotypic diversity in M. bovis.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
MarÃlia Masello Junqueira Franco, Márcio Garcia Ribeiro, Fernando Rogério Pavan, Marcelo Miyata, Marcos Bryan Heinemann, Antonio Francisco de Souza Filho, Rosilene Fressatti Cardoso, Aryadne Larissa de Almeida, Ricardo Ichiro Sakate,